- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:37 | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 14:36 | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control | 81 | GlobeNewswire (Europe) | - Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining... ► Artikel lesen | |
| 03.06. | Alpha Tau teams with Tolmar on lucrative prostate cancer deal | 1 | Globes | ||
| 03.06. | Alpha Tau Medical Ltd.; Tolmar Inc.: Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT Therapy to U.S. Urological Cancer Patients | 2 | GlobeNewswire (USA) | ||
| 03.06. | H.C. Wainwright bestätigt Kaufempfehlung für Alpha Tau Medical nach Studiendaten | - | Investing.com Deutsch | ||
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 03.06. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial data | 1 | Investing.com | ||
| 01.06. | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | 438 | GlobeNewswire (Europe) | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| 01.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.05. | Barclays startet Coverage für Alpha Tau Medical mit "Overweight" | 1 | Investing.com Deutsch | ||
| 28.05. | Barclays initiates Alpha Tau Medical stock with overweight rating | 1 | Investing.com | ||
| 20.05. | H.C. Wainwright reiterates Buy on Alpha Tau stock, $15 target | 1 | Investing.com | ||
| 19.05. | Piper Sandler hebt Kursziel für Alpha Tau Medical nach Meilensteinen an | 2 | Investing.com Deutsch | ||
| 19.05. | Piper Sandler raises Alpha Tau Medical stock price target on milestones | 1 | Investing.com | ||
| 18.05. | Alpha Tau Medical GAAP EPS of -$0.26 | 3 | Seeking Alpha | ||
| 18.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update | 2.092 | GlobeNewswire (Europe) | - Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile - - Completion of... ► Artikel lesen | |
| 18.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.05. | H.C. Wainwright raises Alpha Tau Medical stock price target to $15 on trial data | 3 | Investing.com | ||
| 12.05. | H.C. Wainwright hebt Kursziel für Alpha Tau Medical nach Studiendaten auf 15 US-Dollar an | 1 | Investing.com Deutsch | ||
| 11.05. | Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally | 1 | Benzinga.com | ||
| 11.05. | Studienerfolg bei Hirntumoren: Aktie von Alpha Tau Medical legt kräftig zu | 2 | Investing.com Deutsch |
1 2 3 4 Weiter >>
61 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,575 | -1,93 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| ORGANON | 11,660 | +0,60 % | FDA erweitert Indikationen für Tocilizumab-Biosimilar von Organon | ||
| CO-DIAGNOSTICS | 4,630 | -5,12 % | Co-Diagnostics sichert sich Exklusivvertrieb in Mexiko | ||
| SENSEONICS | 6,650 | +4,72 % | Senseonics, Welldoc partner on next-gen Eversense 365 app development | ||
| VIRIDIAN THERAPEUTICS | 14,200 | +3,65 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,000 | +1,09 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| VYOME | 2,170 | +0,46 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| AXOGEN | 36,030 | +2,01 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| EMBECTA | 2,756 | -1,36 % | Dividendenbekanntmachungen (28.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACTIVIA PROPERTIES INC JP3047490002 3169 JPY 17,0809 EUR ADVANCED MEDICAL SOLUTIONS GROUP PLC GB0004536594 0,0201 GBP 0,0232 EUR AIA... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,680 | -8,28 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| TACTILE SYSTEMS TECHNOLOGY | 22,320 | -0,89 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 4,240 | +5,47 % | Der durch STRC besicherte Stablecoin von Apyx erleidet eine kurze Entkopplung. Das Protokoll bezeichnet dies als Funktion, nicht als Fehler | ||
| GLAUKOS | 105,00 | -1,87 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,656 | +0,02 % | Lexaria Bioscience Corp.: Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway | Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary DehydraTECH KELOWNA, BC / ACCESS Newswire / June 9, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria"... ► Artikel lesen | |
| ITONIC | 0,450 | +4,41 % | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen |
ALPHA TAU MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +4,17 % bei einem Aktienkurs von 9,625 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.